A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis
about
A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis
description
im Oktober 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 20 October 2011
@en
name
A phase III, randomized, contr ...... n moderate-to-severe psoriasis
@en
type
label
A phase III, randomized, contr ...... n moderate-to-severe psoriasis
@en
prefLabel
A phase III, randomized, contr ...... n moderate-to-severe psoriasis
@en
P2093
P356
P1476
A phase III, randomized, contr ...... n moderate-to-severe psoriasis
@en
P2093
Alice B Gottlieb
David A Williams
Gerald G Krueger
Joaquin M Valdes
Kenneth B Gordon
Richard G Langley
P2888
P304
P356
10.1038/JID.2011.304
P407
P577
2011-10-20T00:00:00Z
P6179
1016929175